| Fueling the fire: inflammatory forms of cell death and implications for cancer immunotherapy SR Rosenbaum, NA Wilski, AE Aplin Cancer Discovery 11 (2), 266-281, 2021 | 113 | 2021 |
| RAC 1 P29S regulates PD‐L1 expression in melanoma HL Vu, S Rosenbaum, TJ Purwin, MA Davies, AE Aplin Pigment cell & melanoma research 28 (5), 590-598, 2015 | 72 | 2015 |
| Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanoma C Capparelli, S Rosenbaum, AC Berger, AE Aplin Journal of Biological Chemistry 290 (40), 24267-24277, 2015 | 64 | 2015 |
| FOXD3 regulates VISTA expression in melanoma SR Rosenbaum, M Knecht, M Mollaee, Z Zhong, DA Erkes, PA McCue, ... Cell reports 30 (2), 510-524. e6, 2020 | 59 | 2020 |
| CADM1 is a TWIST1-regulated suppressor of invasion and survival EJ Hartsough, MB Weiss, SA Heilman, TJ Purwin, CH Kugel III, ... Cell death & disease 10 (4), 281, 2019 | 40 | 2019 |
| Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma C Capparelli, TJ Purwin, MK Glasheen, S Caksa, M Tiago, N Wilski, ... Nature communications 13 (1), 1381, 2022 | 37 | 2022 |
| ErbB3–ErbB2 complexes as a therapeutic target in a subset of wild-type BRAF/NRAS cutaneous melanomas C Capparelli, S Rosenbaum, LD Berman-Booty, A Salhi, N Gaborit, ... Cancer research 75 (17), 3554-3567, 2015 | 23 | 2015 |
| MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRASáMelanoma HL Vu, S Rosenbaum, C Capparelli, TJ Purwin, MA Davies, AC Berger, ... Journal of Investigative Dermatology 136 (2), 453-463, 2016 | 17 | 2016 |
| SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects SR Rosenbaum, M Tiago, S Caksa, C Capparelli, TJ Purwin, G Kumar, ... Cell reports 37 (10), 2021 | 13 | 2021 |
| Fueling the fire: Inflammatory forms of cell death and implications for cancer immunotherapy. Cancer Discov. 2021; 11: 266–281. doi: 10.1158/2159-8290 SR Rosenbaum, NA Wilski, AE Aplin CD-20-0805.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 9 | |
| PLX3397 inhibits the accumulation of intra‐tumoral macrophages and improves bromodomain and extra‐terminal inhibitor efficacy in melanoma DA Erkes, SR Rosenbaum, CO Field, I Chervoneva, J Villanueva, ... Pigment cell & melanoma research 33 (2), 372-377, 2020 | 8 | 2020 |
| CADM1 is a TWIST1 regulated suppressor of melanoma invasion EJ Hartsough, MB Weiss, CH Kugel, SR Rosenbaum, AE Aplin Cancer Research 75 (15_Supplement), 4089-4089, 2015 | 3 | 2015 |
| Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy. Cancer Discov. 2021; 11: 266–81 SR Rosenbaum, NA Wilski, AE Aplin | 3 | |
| SOX10 loss sensitizes melanoma cells to cytokine-mediated inflammatory cell death SR Rosenbaum, S Caksa, CD Stefanski, IV Trachtenberg, HP Wilson, ... Molecular Cancer Research 22 (2), 209-220, 2024 | | 2024 |
| The aged tumor microenvironment influences tolerance to targeted therapy via NR2F1 overexpression in BRAF-mutant melanoma M Tiago, TJ Purwin, ME Fane, Y Chhabra, JLF Teh, R Kadamb, W Cai, ... CANCER RESEARCH 83 (2), 2023 | | 2023 |
| Abstract A005: The aged tumor microenvironment influences tolerance to targeted therapy via NR2F1 overexpression in BRAF-mutant melanoma M Tiago, TJ Purwin, ME Fane, Y Chhabra, JLF Teh, R Kadamb, W Cai, ... Cancer Research 83 (2_Supplement_1), A005-A005, 2023 | | 2023 |
| Targeting SOX10-deficient cells to reduce resistance to targeted therapy in melanoma C Capparelli, TJ Purwin, M Tiago, N Wilski, D Pomante, MK Glasheen, ... Cancer Research 81 (13_Supplement), 40-40, 2021 | | 2021 |
| The Role of Lineage-specific Transcription Factors in Regulating Anti-tumor Immune Responses in Melanoma S Rosenbaum Thomas Jefferson University, 2021 | | 2021 |
| The next-generation BET inhibitor, PLX51107, delays melanoma growth, altering the tumor immune microenvironment via Cox2 inhibition. DA Erkes, CO Field, C Capparelli, M Tiago, TJ Purwin, SA Heilman, ... CANCER IMMUNOLOGY RESEARCH 8 (4), 55-55, 2020 | | 2020 |
| Abstract A33: The next-generation BET inhibitor, PLX51107, delays melanoma growth, altering the tumor immune microenvironment via Cox2 inhibition DA Erkes, CO Field, C Capparelli, M Tiago, TJ Purwin, SA Heilman, ... Cancer Immunology Research 8 (4_Supplement), A33-A33, 2020 | | 2020 |
